Delivery Order SPE2DB20D1110-SPE2DB25FK13S
Award Date 5/12/25
Potential Completion Date 5/13/25
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on December 11, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $4,437.77. This is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order (4570164033) by the Defense Logistics Agency (DLA) on December 3, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $8,022.58. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 4, 2025. The award reflects a routine pharmaceutical procurement supporting federal healthcare needs, with performance to be executed at AmerisourceBergen's facility in...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,257.08 by the Defense Logistics Agency on December 5, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, demonstrating...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This competitive, firm fixed-price contract carries a ceiling value of $10,834.58 and is scheduled for completion by September 3, 2025. The award was executed under a non-set-aside procurement, and performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,843.93 by the Defense Logistics Agency (DLA) on December 11, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging). The contract is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through competitive procurement with no set-aside designation and represents a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Eliquis 2.5 mg tablets (60-count packages) with a ceiling value of $1,570.80. This is a firm fixed price delivery order with an ultimate completion date of June 2, 2025, and no set-aside designation was used in the award. The contract represents a competitive procurement action within the pharmaceutical supply chain...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $20,323.56. This is a firm fixed price delivery order with an ultimate completion date of October 17, 2025, and represents a non-competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 12, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price delivery order carries a ceiling value of $71,179.72 and is scheduled for ultimate completion by May 13, 2025. The award was made through open competition with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $11,836.46. This firm fixed-price delivery order, which must be completed by April 22, 2025, represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award utilized no set-aside provisions and was competitively awarded, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $13,452.67. This firm fixed-price delivery order is scheduled for completion by July 21, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued without set-aside restrictions, drawing from AmerisourceBergen's existing...